PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1880580
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1880580
Canine Vaccines Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of canine vaccines Market
The global canine vaccines market continues its steady expansion, driven by rising pet ownership, growing awareness of preventive veterinary care, and increasing government and industry focus on combating zoonotic diseases. According to the latest market data, the canine vaccines market size reached USD 1.87 billion in 2024, supported by strong vaccination adoption across developed and emerging economies. The market is projected to rise to USD 1.95 billion in 2025 and further accelerate to USD 3.04 billion by 2032, reflecting the sustained commitment to pet health, advancements in vaccine platforms, and expansion of veterinary infrastructure.
Market Growth Drivers
The most influential driver of market growth is the rapid rise in global dog ownership. Pet parents increasingly view dogs as family members, leading to growing investments in advanced veterinary services, including routine and preventive vaccinations. In the U.S. alone, the Global Animal Health Association reported around 85 million pet dogs, presenting a strong foundation for long-term vaccine demand. Growing concerns about infectious diseases such as canine influenza, Lyme disease, rabies, and parvovirus further strengthen the necessity for timely immunization.
Government initiatives also contribute substantially to market expansion. With zoonotic diseases posing public health risks, authorities across the world are promoting mass vaccination programs. Increased investment in public health education, partnerships with veterinary associations, and free or subsidized vaccination campaigns encourage higher adoption rates. Simultaneously, rising disposable income and the broader pet humanization trend support increased veterinary expenditures.
Market Restraints
Despite positive growth prospects, the industry faces a few restraints. Vaccine hesitancy among a segment of pet owners slows market adoption, primarily due to concerns about potential side effects or lack of awareness about the frequency and necessity of vaccinations. According to GAVI, 4% of dogs and 12% of cats remain unvaccinated against rabies, highlighting the need for enhanced outreach and educational programs.
Another significant barrier is the shortage of veterinary professionals. Veterinary practices worldwide continue to experience limited staff availability, resulting in reduced appointment capacity and a decline in clinic visits. Between 2021 and 2023, the American Veterinary Medical Association reported a 2.7% decline in client visits, which may hinder consistent immunization compliance.
Market Opportunities
The market is witnessing strong opportunities in the development of novel combination vaccines. These formulations provide multi-disease protection with fewer doses, improving convenience and enhancing immune response. For example, Elanco received USDA approval in July 2025 for TruCan Ultra CIV H3N2/H3N8, a next-generation canine influenza combination vaccine using PureFil Technology to minimize adverse reactions.
The growing prevalence of zoonotic diseases and heightened focus on comprehensive pet care are also pushing pharmaceutical companies toward developing recombinant and precision-targeted vaccines. Strengthened regulatory support and rising investments in veterinary R&D further expand opportunities for innovation in this sector.
Market Trends
A leading trend in the canine vaccines industry is the shift toward easy-to-administer vaccine formats, particularly intranasal and oral vaccines. These modes reduce stress on pets, minimize handling requirements, and activate rapid mucosal immune responses. In March 2025, Zoetis introduced the Vanguard B Intranasal vaccine, a 0.5 mL formulation offering protection against Bordetella bronchiseptica, showcasing the market's movement toward user-friendly vaccine delivery.
Regional Insights
North America - Market Leader
North America held the largest share of the global market in 2024, valued at USD 0.84 billion, representing 44.91% of global revenue. The region benefits from high pet adoption, advanced veterinary care, and significant presence of leading manufacturers such as Zoetis, Merck & Co., and Elanco. The U.S. remains the largest contributor due to strong guidelines for canine vaccination and increased spending on companion animal healthcare.
Europe
Europe is expected to exhibit considerable growth, supported by increasing awareness of canine disease risks and higher pet ownership. The U.K., with 28% of adults owning dogs, is a key contributor to regional expansion.
Asia Pacific
Asia Pacific is forecast to grow at the fastest rate through 2032. The rise in urban pet ownership, new product introductions, and partnerships-such as Bioveta's collaboration with Vetina Healthcare in India-support rapid market development.
Latin America & Middle East & Africa
These regions show moderate but steady growth, strongly supported by government-led rabies vaccination programs and rising awareness of companion animal health.
Competitive Landscape
The market is semi-fragmented, with major players including Zoetis Services LLC, Merck & Co., Inc., Elanco, Virbac, Ceva, Bioveta, Indian Immunologicals Ltd., HIPRA, and Brilliant Bio Pharma. These companies are expanding through new product launches, multi-disease vaccine development, strategic partnerships, and investment in advanced manufacturing capabilities.
Segmentation By Technology
- Inactivated
- Live Attenuated
- Recombinant
- Others
By Disease Type
- Canine Influenza
- Lyme Disease
- Rabies
- Leptospirosis
- Others
By Route of Administration
- Oral
- Parenteral
- Intranasal
By Distribution Channel
- Veterinary Hospitals
- Veterinary Clinics
- Pharmacies & Drug Stores
- Others
By Region
- North America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
- U.S.
- Canada
- Europe (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Asia Pacific (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
- Japan
- China
- India
- Australia
- Southeast Asia
- Rest of Asia Pacific
- Latin America (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa (By Technology, By Disease Type, By Route of Administration, By Distribution Channel, By Country/ Sub-Region)
- GCC
- South Africa
- Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Overview of Canine Diseases by Key Countries, By Key Countries/ Region, 2024
- 4.2. Regulatory Scenario by Key Countries/ Region, 2024
- 4.3. Overview of Vaccination for Canine Diseases
- 4.4. New Technology Launches, By Key Players
- 4.5. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
5. Global Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast - By Technology
- 5.1.1. Inactivated
- 5.1.2. Live Attenuated
- 5.1.3. Recombinant
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - By Disease Type
- 5.2.1. Canine Influenza
- 5.2.2. Lyme Disease
- 5.2.3. Rabies
- 5.2.4. Leptospirosis
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast - By Route of Administration
- 5.3.1. Oral
- 5.3.2. Parenteral
- 5.3.3. Intranasal
- 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 5.4.1. Veterinary Hospitals
- 5.4.2. Veterinary Clinics
- 5.4.3. Pharmacies & Drug Stores
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast - By Technology
- 6.1.1. Inactivated
- 6.1.2. Live Attenuated
- 6.1.3. Recombinant
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast - By Disease Type
- 6.2.1. Canine Influenza
- 6.2.2. Lyme Disease
- 6.2.3. Rabies
- 6.2.4. Leptospirosis
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast - By Route of Administration
- 6.3.1. Oral
- 6.3.2. Parenteral
- 6.3.3. Intranasal
- 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.4.1. Veterinary Hospitals
- 6.4.2. Veterinary Clinics
- 6.4.3. Pharmacies & Drug Stores
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast - By Technology
- 7.1.1. Inactivated
- 7.1.2. Live Attenuated
- 7.1.3. Recombinant
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast - By Disease Type
- 7.2.1. Canine Influenza
- 7.2.2. Lyme Disease
- 7.2.3. Rabies
- 7.2.4. Leptospirosis
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast - By Route of Administration
- 7.3.1. Oral
- 7.3.2. Parenteral
- 7.3.3. Intranasal
- 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.4.1. Veterinary Hospitals
- 7.4.2. Veterinary Clinics
- 7.4.3. Pharmacies & Drug Stores
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast - By Technology
- 7.5.1. Inactivated
- 7.5.2. Live Attenuated
- 7.5.3. Recombinant
- 7.5.4. Others
- 7.6. Market Analysis, Insights and Forecast - By Disease Type
- 7.6.1. Canine Influenza
- 7.6.2. Lyme Disease
- 7.6.3. Rabies
- 7.6.4. Leptospirosis
- 7.6.5. Others
- 7.7. Market Analysis, Insights and Forecast - By Route of Administration
- 7.7.1. Oral
- 7.7.2. Parenteral
- 7.7.3. Intranasal
- 7.8. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.8.1. Veterinary Hospitals
- 7.8.2. Veterinary Clinics
- 7.8.3. Pharmacies & Drug Stores
- 7.8.4. Others
- 7.9. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 7.9.1. Germany
- 7.9.2. U.K.
- 7.9.3. France
- 7.9.4. Italy
- 7.9.5. Spain
- 7.9.6. Scandinavia
- 7.9.7. Rest of Europe
8. Asia Pacific Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast - By Technology
- 8.1.1. Inactivated
- 8.1.2. Live Attenuated
- 8.1.3. Recombinant
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast - By Disease Type
- 8.2.1. Canine Influenza
- 8.2.2. Lyme Disease
- 8.2.3. Rabies
- 8.2.4. Leptospirosis
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast - By Route of Administration
- 8.3.1. Oral
- 8.3.2. Parenteral
- 8.3.3. Intranasal
- 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.4.1. Veterinary Hospitals
- 8.4.2. Veterinary Clinics
- 8.4.3. Pharmacies & Drug Stores
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 8.5.1. China
- 8.5.2. Japan
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast - By Technology
- 9.1.1. Inactivated
- 9.1.2. Live Attenuated
- 9.1.3. Recombinant
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast - By Disease Type
- 9.2.1. Canine Influenza
- 9.2.2. Lyme Disease
- 9.2.3. Rabies
- 9.2.4. Leptospirosis
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast - By Route of Administration
- 9.3.1. Oral
- 9.3.2. Parenteral
- 9.3.3. Intranasal
- 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.4.1. Veterinary Hospitals
- 9.4.2. Veterinary Clinics
- 9.4.3. Pharmacies & Drug Stores
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa Canine Vaccines Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast - By Technology
- 10.1.1. Inactivated
- 10.1.2. Live Attenuated
- 10.1.3. Recombinant
- 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast - By Disease Type
- 10.2.1. Canine Influenza
- 10.2.2. Lyme Disease
- 10.2.3. Rabies
- 10.2.4. Leptospirosis
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast - By Route of Administration
- 10.3.1. Oral
- 10.3.2. Parenteral
- 10.3.3. Intranasal
- 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.4.1. Veterinary Hospitals
- 10.4.2. Veterinary Clinics
- 10.4.3. Pharmacies & Drug Stores
- 10.4.4. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2024)
- 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability)
- 11.2.1. Elanco
- 11.2.2. Boehringer Ingelheim International GmbH
- 11.2.3. Virbac
- 11.2.4. Merck & Co., Inc.
- 11.2.5. Zoetis Services LLC
- 11.2.6. Ceva
- 11.2.7. Bioveta, a.s.
- 11.2.8. Indian Immunologicals Ltd.
- 11.2.9. HIPRA
- 11.2.10. Brilliant Bio Pharma (India)
List of Tables
- Table 1: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
- Table 2: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
- Table 3: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
- Table 4: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 5: Global Canine Vaccines Market Revenue (USD billion) Forecast, by Region, 2019-2032
- Table 6: North America Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
- Table 7: North America Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
- Table 8: North America Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
- Table 9: North America Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 10: North America Canine Vaccines Market Revenue (USD billion) Forecast, By Country, 2019-2032
- Table 11: Europe Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
- Table 12: Europe Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
- Table 13: Europe Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
- Table 14: Europe Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 15: Europe Canine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
- Table 16: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
- Table 17: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
- Table 18: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
- Table 19: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 20: Asia Pacific Canine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
- Table 21: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
- Table 22: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
- Table 23: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
- Table 24: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 25: Latin America Canine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
- Table 26: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, by Technology, 2019-2032
- Table 27: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, by Disease Type, 2019-2032
- Table 28: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032
- Table 29: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 30: Middle East & Africa Canine Vaccines Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
List of Figures
- Figure 1: Global Canine Vaccines Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
- Figure 2: Global Canine Vaccines Market Value Share (%), by Technology, 2024 & 2032
- Figure 3: Global Canine Vaccines Market Value Share (%), by Disease Type, 2024 & 2032
- Figure 4: Global Canine Vaccines Market Value Share (%), by Route of Administration, 2024 & 2032
- Figure 5: Global Canine Vaccines Market Value Share (%), by Distribution Channel, 2024 & 2032
- Figure 6: Global Canine Vaccines Market Value Share (%), by Region, 2024 & 2032
- Figure 7: North America Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
- Figure 8: North America Canine Vaccines Market Value Share (%), by Technology, 2024
- Figure 9: North America Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
- Figure 10: North America Canine Vaccines Market Value Share (%), by Disease Type, 2024
- Figure 11: North America Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
- Figure 12: North America Canine Vaccines Market Value Share (%), by Route of Administration, 2024
- Figure 13: North America Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 14: North America Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 15: North America Canine Vaccines Market Value (USD billion), By Country, 2024 & 2032
- Figure 16: North America Canine Vaccines Market Value Share (%), By Country, 2024
- Figure 17: Europe Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
- Figure 18: Europe Canine Vaccines Market Value Share (%), by Technology, 2024
- Figure 19: Europe Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
- Figure 20: Europe Canine Vaccines Market Value Share (%), by Disease Type, 2024
- Figure 21: Europe Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
- Figure 22: Europe Canine Vaccines Market Value Share (%), by Route of Administration, 2024
- Figure 23: Europe Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 24: Europe Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 25: Europe Canine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 26: Europe Canine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
- Figure 27: Asia Pacific Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
- Figure 28: Asia Pacific Canine Vaccines Market Value Share (%), by Technology, 2024
- Figure 29: Asia Pacific Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
- Figure 30: Asia Pacific Canine Vaccines Market Value Share (%), by Disease Type, 2024
- Figure 31: Asia Pacific Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
- Figure 32: Asia Pacific Canine Vaccines Market Value Share (%), by Route of Administration, 2024
- Figure 33: Asia Pacific Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 34: Asia Pacific Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 35: Asia Pacific Canine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 36: Asia Pacific Canine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
- Figure 37: Latin America Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
- Figure 38: Latin America Canine Vaccines Market Value Share (%), by Technology, 2024
- Figure 39: Latin America Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
- Figure 40: Latin America Canine Vaccines Market Value Share (%), by Disease Type, 2024
- Figure 41: Latin America Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
- Figure 42: Latin America Canine Vaccines Market Value Share (%), by Route of Administration, 2024
- Figure 43: Latin America Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 44: Latin America Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 45: Latin America Canine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 46: Latin America Canine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
- Figure 47: Middle East & Africa Canine Vaccines Market Value (USD billion), by Technology, 2024 & 2032
- Figure 48: Middle East & Africa Canine Vaccines Market Value Share (%), by Technology, 2024
- Figure 49: Middle East & Africa Canine Vaccines Market Value (USD billion), by Disease Type, 2024 & 2032
- Figure 50: Middle East & Africa Canine Vaccines Market Value Share (%), by Disease Type, 2024
- Figure 51: Middle East & Africa Canine Vaccines Market Value (USD billion), by Route of Administration, 2024 & 2032
- Figure 52: Middle East & Africa Canine Vaccines Market Value Share (%), by Route of Administration, 2024
- Figure 53: Middle East & Africa Canine Vaccines Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 54: Middle East & Africa Canine Vaccines Market Value Share (%), by Distribution Channel, 2024
- Figure 55: Middle East & Africa Canine Vaccines Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
- Figure 56: Middle East & Africa Canine Vaccines Market Value Share (%), By Country/ Sub-region, 2024
- Figure 57: Global Canine Vaccines Market Share (%), By Company, 2024
